ClinicaSpace.com
Clinical Research
News & Careers
 
Search the Site
    
 
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   

By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile

 

Clovis Oncology 

1871 Folsom Street

Boulder  Colorado  80302  U.S.A.
Phone: n/a Fax: n/a


SEARCH JOBS








 Company News
Clovis Oncology (CLVS) Announces First Patient Enrolled in Lucitanib Phase 2 Study In FGF-aberrant Advanced Breast Cancer 9/11/2014 11:17:08 AM
Clovis Oncology (CLVS) Announces Exercise In Full By Initial Purchasers Of Their Option To Purchase An Additional $37.5 Million Aggregate Principal Amount Of The Company’s 2.50% Convertible Senior Notes Due 2021 9/9/2014 10:36:55 AM
Clovis Oncology (CLVS) To Present At The 2014 Morgan Stanley Global Healthcare Conference 9/8/2014 10:00:20 AM
Clovis Oncology (CLVS) Announces Pricing Of $250 Million Of Convertible Senior Notes 9/4/2014 12:36:52 PM
Clovis Oncology (CLVS) To Offer $200 Million Of Convertible Senior Notes 9/3/2014 1:49:54 PM
Clovis Oncology (CLVS) Announces Second Quarter 2014 Operating Results 8/8/2014 9:06:05 AM
Clovis Oncology (CLVS) To Announce Second Quarter 2014 Financial Results And Host Webcast Conference Call On August 7 7/22/2014 12:21:41 PM
Clovis Oncology (CLVS) Announces First Patient Enrolled In TIGER2 Study 6/23/2014 12:19:44 PM
Clovis Oncology (CLVS) Announces First Patient Enrolled In RUCAPANC Study 6/16/2014 10:31:57 AM
Clovis Oncology (CLVS) Shares Drop As Analysts Give Edge To Lung-Cancer Rival 6/4/2014 7:05:16 AM
123456789